Audrey Arjomandi
Overview
Explore the profile of Audrey Arjomandi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
3
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mai T, Yadav R, Arjomandi A, Jung C, Meier M, Donaldson F, et al.
Clin Pharmacol Drug Dev
. 2024 Apr;
13(6):655-664.
PMID: 38651245
Zinpentraxin alfa is a recombinant form of the human pentraxin-2 that was studied in idiopathic pulmonary fibrosis (IPF). To improve the purity and yield of the drug material, a 2nd-generation...
2.
Arjomandi A, Siradze K, Cheu M, Davancaze T, Yadav R, Rao G, et al.
AAPS J
. 2024 Jan;
26(1):16.
PMID: 38267613
Immunogenicity assessment is an essential part of biotherapeutic drug development. While the immune response in animals is not always representative of the human immune response, immunogenicity data obtained in animal...
3.
Rao G, Santagostino S, Wong L, Inoue A, Arjomandi A, Yadav R, et al.
Reprod Toxicol
. 2023 Dec;
123:108526.
PMID: 38141866
Zinpentraxin alfa is a recombinant human pentraxin-2 (PTX-2) developed for the treatment of various fibrotic diseases with the hypothesis that supplementing endogenous PTX-2 levels through intravenous administration should increase its...
4.
Li M, Arjomandi A, Sun X, Lu E, Tyagi T, Lin W, et al.
AAPS J
. 2023 Dec;
26(1):9.
PMID: 38114736
Idiopathic pulmonary fibrosis (IPF) is a progressive fatal interstitial lung disease that affects three million patients worldwide and currently without an effective cure. Zinpentraxin alfa, a recombinant human pentraxin-2 (rhPTX-2)...
5.
Yang X, Siradze K, Sperinde G, Arjomandi A, Fischer S
J Immunol Methods
. 2023 Oct;
522:113573.
PMID: 37816404
Zinpentraxin alfa (rhPTX-2; PRM-151) is currently being developed for the treatment of fibrotic diseases such as idiopathic pulmonary fibrosis and myelofibrosis. Notably, because it is administered chronically and has an...
6.
Arjomandi A, Delanoy M, Walker R, Binder S
Cancer Treat Res Commun
. 2018 Sep;
15:32-35.
PMID: 30207285
Background: Measurement of autoantibodies (AAbs) to tumor associated antigens has been proposed to aid in the early detection of ovarian cancer with high specificity. Here we describe a multiplex approach...